MDT
MDT
IE00BTN1Y115
Medtronic plc.
Loading chart...

Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Latest News

Related stocks

SHL.DE
SHL.DE • Germany
Siemens Healthineers AG N
39.14 EUR
49.09B USD 1Y -21.2%
PHIA.AS
PHIA.AS • Netherlands
KON.PHILIPS N.V.
21.78 EUR
23.86B USD 1Y -11.6%
PHG
PHG • Netherlands
Koninklijke Philips N.V. NY Reg
24.24 USD
23.69B USD 1Y -14%
SYK
SYK • United States
Stryker Corporation
277.33 USD
106.38B USD 1Y -26.2%
ABT
ABT • United States
Abbott Laboratories
99.6 USD
173.48B USD 1Y -26.6%
SNN
SNN • United Kingdom
Smith & Nephew SNATS, Inc.
27.24 USD
11.4B USD 1Y -25%
SN.L
SN.L • United Kingdom
SMITH & NEPHEW PLC ORD USD0.20
1,020.5 GBp
11.3B USD 1Y -25.3%
SOON.SW
SOON.SW • Switzerland
SONOVA N
264.6 CHF
18.94B USD 1Y +14.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
22.6% p.a.
Max Drawdown (5Y)
-45.6%
Sharpe Ratio (5Y)
-0.42
Beta Factor
0.57
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Historical Stress Test: Maximum peak-to-trough drawdown of -48.6% in the extended horizon.
ende